Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Tacoma WA, Vancouver, Grand Junction CO, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

for
Lysosomal Acid Lipase Deficiency,
Location: Tacoma WA, Edmonton, Stanford CA, Phoenix AZ,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT01633489

Recruiting

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

for
Diffuse Large B-Cell Lymphoma
Location: Tacoma WA, Des Moines IA
Sponsor: AstraZeneca

Sex: All

Age: 65 - 70+

Code: NCT05952024

Phase2, Recruiting

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

for
Sepsis, Length of Stay, Mortality, Neurodevelopmental Delay
Location: Tacoma WA
Sponsor: University of Washington

Sex: All

Age: 0 - 2

Code: NCT06893939

Phase2, Phase3, Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

for
Paroxysmal Atrial Fibrillation
Location: Tacoma WA, Puyallup WA, Ventura CA, Aurora CO,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT06324201

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Tacoma WA, Saskatoon, Grand Junction CO, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Tacoma WA, Edmonton, Denver CO, Scottsdale AZ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Tacoma WA, Salem OR, Las Vegas NV, Los Alamitos CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase3, Recruiting

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

for
Metastatic Breast Cancer, ER-positive Breast Cancer,
Location: Tacoma WA, San Francisco CA, Aurora CO, Gilbert AZ,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05508906

Phase1, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Tacoma WA, Salem OR, San Francisco CA, Duarte CA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Tacoma WA, Portland OR, Salem OR, Redmond OR, Bend OR,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase3, Recruiting

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma (HCC)
Location: Tacoma WA, Olympia WA, Glendale CA, Houston TX,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18 - 65

Code: NCT07176650

Phase1, Recruiting

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Tacoma WA, Los Angeles CA, Baton Rouge LA, Bethesda MD
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07609940

Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Tacoma WA, Salt Lake City UT, Clovis CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Tacoma WA, Vancouver, Portland OR, Edmonton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for
Prostate Cancer,
Location: Tacoma WA, Santa Rosa CA, Anaheim CA, Albuquerque NM,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT04729114

Phase1, Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

for
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype,
Location: Tacoma WA, Glendale CA, Beverly Hills CA,
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06047379

Phase1, Phase2, Recruiting

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

for
EGFRI Induced Acneiform Lesions
Location: Tacoma WA, Glendale CA, Santa Monica CA, Shreveport LA,
Sponsor: Lutris Pharma Ltd.

Sex: All

Age: 18+

Code: NCT04759664

Phase2, Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

for
Breast Neoplasms, Carcinoma, Ductal, Breast,
Location: Tacoma WA, Puyallup WA, Stockton CA, Dyer IN,
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07214532

Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Tacoma WA, Yakima WA, Salem OR, Spokane WA, Reno NV,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase3, Recruiting